Literature DB >> 1361179

Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult.

J A Shizuru1, S E Alters, C G Fathman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361179     DOI: 10.1111/j.1600-065x.1992.tb01421.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  6 in total

Review 1.  The molecular basis for T cell help in humoral immunity: CD40 and its ligand, gp39.

Authors:  L S Marshall; A Aruffo; J A Ledbetter; R J Noelle
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

Review 2.  Cross-linking reconsidered: binding and cross-linking fields and the cellular response.

Authors:  B Sulzer; R J De Boer; A S Perelson
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

3.  The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands.

Authors:  J Madrenas; L A Chau; J Smith; J A Bluestone; R N Germain
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

Review 4.  Responses against complex antigens in various models of CD4 T-cell deficiency: surprises from an anti-CD4 antibody transgenic mouse.

Authors:  Yifan Zhan; Lorena E Brown; Georgia Deliyannis; Shirley Seah; Odilia L Wijburg; Jason Price; Richard A Strugnell; Phillip J O'Connell; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  Activation of CD4+ T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro.

Authors:  P Stumbles; D Mason
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

6.  The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules [corrected].

Authors:  J M Penninger; N Neu; E Timms; V A Wallace; D R Koh; K Kishihara; C Pummerer; T W Mak
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.